Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdiaVita in Chronic Mechanical Lower Back Pain
NCT07587047Phase 1Recruiting
- Sponsor
- Adia Med, LLC
- Start
- Jun 2026
- Primary completion
- Jan 2028
- Modality
- Lipid-based Nanoparticles, Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of AdiaVita in low back pain (LBP) (2 arms), sponsored by Adia Med, LLC. Primary endpoints: Change in Average Low Back Pain Intensity at Month 3 and Change in Functional Disability at Month 3. Started Jun 2026; status: recruiting.
02
Drugs
AdiaVita
03
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT07587047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07587047.